Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Equity Ratio (2021 - 2025)

Indivior Pharmaceuticals (INDV) has 4 years of Equity Ratio data on record, last reported at 0.15 in Q3 2025.

  • For Q3 2025, Equity Ratio changed N/A year-over-year to 0.15; the TTM value through Sep 2025 reached 0.15, changed N/A, while the annual FY2024 figure was 0.26, 144.67% down from the prior year.
  • Equity Ratio reached 0.15 in Q3 2025 per INDV's latest filing, up from 0.26 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.07 in Q4 2021 and bottomed at 0.26 in Q4 2024.
  • Average Equity Ratio over 4 years is 0.11, with a median of 0.13 recorded in 2025.
  • The widest YoY moves for Equity Ratio: up 144.67% in 2024, down 144.67% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 0.07 in 2021, then tumbled by 258.47% to 0.1 in 2023, then crashed by 144.67% to 0.26 in 2024, then surged by 42.91% to 0.15 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.15 in Q3 2025, 0.26 in Q4 2024, and 0.1 in Q4 2023.